Hamman-Rich syndrome: Difference between revisions
Jump to navigation
Jump to search
Gerald Chi- (talk | contribs) No edit summary |
Gerald Chi- (talk | contribs) No edit summary |
||
Line 1: | Line 1: | ||
{{Infobox disease | | {{Infobox disease | | ||
Name = Hamman–Rich syndrome | | Name = Hamman–Rich syndrome | | ||
Line 6: | Line 4: | ||
ICD9 = {{ICD9|516.3}} | | ICD9 = {{ICD9|516.3}} | | ||
ICDO = | | ICDO = | | ||
Image = | Image = Hyaline membranes - very high mag.jpg | | ||
Caption = [[Micrograph]] of [[diffuse alveolar damage]], the histologic correlate of acute interstitial pneumonitis. [[H&E stain]]. | | Caption = [[Micrograph]] of [[diffuse alveolar damage]], the histologic correlate of acute interstitial pneumonitis. [[H&E stain]]. | | ||
OMIM = 178500 | | OMIM = 178500 | | ||
Line 16: | Line 14: | ||
}} | }} | ||
__NOTOC__ | __NOTOC__ | ||
{{Hamman-Rich syndrome}} | |||
{{CMG}} | {{CMG}} | ||
Revision as of 19:31, 14 February 2014
Hamman–Rich syndrome | |
Classification and external resources | |
Micrograph of diffuse alveolar damage, the histologic correlate of acute interstitial pneumonitis. H&E stain. | |
ICD-10 | J84.1 |
ICD-9 | 516.3 |
OMIM | 178500 |
DiseasesDB | 4815 |
MeSH | D011658 |
Hamman-Rich syndrome Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Hamman-Rich syndrome On the Web |
American Roentgen Ray Society Images of Hamman-Rich syndrome |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Acute interstitial pneumonia; Acute interstitial pneumonitis; HR syndrome
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Hamman-Rich syndrome from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Electrocardiogram | Chest X Ray | CT | MRI | Echocardiography or Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies